Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 19:21:425-431.
doi: 10.1016/j.csbj.2022.12.014. eCollection 2023.

TWN-RENCOD: A novel method for protein binding site comparison

Affiliations

TWN-RENCOD: A novel method for protein binding site comparison

Kwang-Eun Choi et al. Comput Struct Biotechnol J. .

Abstract

Several diverse proteins possess similar binding sites. Protein binding site comparison provides valuable insights for the drug discovery and development. Binding site similarities are useful in understanding polypharmacology, identifying potential off-targets and repurposing of known drugs. Many binding site analysis and comparison methods are available today, however, these methods may not be adequate to explain variation in the activity of a drug or a small molecule against a number of similar proteins. Water molecules surrounding the protein surface contribute to structure and function of proteins. Water molecules form diverse types of hydrogen-bonded cyclic water-ring networks known as topological water networks (TWNs). Analysis of TWNs in binding site of proteins may improve understanding of the characteristics of binding sites. We propose TWN-based residue encoding (TWN-RENCOD), a novel binding site comparison method which compares the aqueous environment in binding sites of similar proteins. As compared to other existing methods, results obtained using our method correlated better with differences in wide range of activity of a known drug (Sunitinib) against nine different protein kinases (KIT, PDGFRA, VEGFR2, PHKG2, ITK, HPK1, MST3, PAK6 and CDK2).

Keywords: Binding site comparison method; Drug repurposing; Protein binding site; Sunitinib; Water network.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

ga1
Graphical abstract
Fig. 1
Fig. 1
The work flow for TWN-RENCOD methodology.
Fig. 2
Fig. 2
An illustration of a 3-membered ring TWN. Water molecules involved in the 3-membered ring TWN are represented by stick models (W1-W3) while hydrogen bond interactions are represented by dotted lines.
Fig. 3
Fig. 3
Superimposed crystal structures of Sunitinib (gray) bound KIT (pink), PDGFRA (yellow), VEGFR2 (chartreuse), PHKG2 (cyan), ITK (blue), HPK1 (green), MST3 (gray), PAK6 (purple) and CDK2 (orange).
Fig. 4
Fig. 4
A heatmap of the binding site similarity values for various protein-pairs computed using different methods, blue colors indicate low similarity values and red colors indicate high similarity values. The differences in activity (log) of Sunitinib for various protein-pairs are shown in parentheses in the magenta color.
Fig. 5
Fig. 5
Correlation between the differences in activity (log) and the differences in binding energy (absolute values in kcal mol−1) of Sunitinib for various protein-pairs.

References

    1. Burley S.K. Impact of structural biologists and the Protein Data Bank on small-molecule drug discovery and development. J Biol Chem. 2021;296 - PMC - PubMed
    1. Jiang M., Li Z., Bian Y., Wei Z. A novel protein descriptor for the prediction of drug binding sites. BMC Bioinform. 2019;20:478. - PMC - PubMed
    1. Kandel J., Tayara H., Chong K.T. PUResNet: prediction of protein-ligand binding sites using deep residual neural network. J Cheminform. 2021;13:65. - PMC - PubMed
    1. Ehrt C., Brinkjost T., Koch O. Impact of binding site comparisons on medicinal chemistry and rational molecular design. J Med Chem. 2016;59(9):4121–4151. - PubMed
    1. Ehrt C., Brinkjost T., Koch O. Binding site characterization–similarity, promiscuity, and druggability. MedChemComm. 2019;10(7):1145–1159. - PMC - PubMed